Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure

Clinical trial NCT01667614 · COMPLETED

Trial details

NCT number: NCT01667614
Sponsor: Tehran University of Medical Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Diabetic Nephropathy Essential Hypertension

Start date: 2010-05-01
Primary completion: 2012-03-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.